5 Questions with Sayeh Nikpay: The 340B Drug Pricing Program | Cornerstone Research : vimarsana.com

A periodic feature by Cornerstone Research, in which our affiliated experts, senior advisors, and professionals, talk about their research and findings. We interview...

Related Keywords

Health Services , Minnesota , United States , South Carolina , Maine , University Of Minnesota , American , Melindab Buntin , Sayeh Nikpay , Adamj Fein , Renam Conti , Claire Mcglave , School Of Public Health , Services Administration , Health Affairs Scholar , B Program , B Program Offer , Cornerstone Research , Genesis Health Care Inc , Sanofi Aventis , Health Services Research , S Government Accountability Office , B Drug Pricing Program Contract Growth , B Health , Us District Court , Health Resources , Health Centers Fqhcs , Health Forum , Third Circuit Court , B Drug Pricing Program , Professor Sayeh Nikpay , Public Health , Drug Pricing Program , Disproportionate Share Hospitals , Federally Qualified Health Centers , Affordable Care Act , Third Circuit , Further Reading , Between Initiation , Hospital Safety Net Engagement , Services Research , Medicaid Windfall , Medicaid Expansions , Target Efficiency , Hospital Safety Net Subsidies , Public Economics , Contract Pharmacy Growth , County Level Characteristics , Managed Care , Drug Pricing Program Contract Growth , Retail Pharmacies , Pharmacy Ownership , Affairs Scholar , Government Accountability Office , Manufacturer Discounts , Program Offer Benefits , Federal Oversight Needs Improvement , Program Reached , Health Care Inc , Should Consider Legal , Operational Burdens Imposed ,